摘要
The microRNA-21 （miR-21） is known to play a major role in cancer progression; however, its function in the cardiovascular system appears to be even more complex and conflicting. To characterize miR-21 expression in the plasma of individuals with or without metabolic syndrome （MetS）, 58 MetS cases and 96 non-MetS controls were investigated.
The microRNA-21 （miR-21） is known to play a major role in cancer progression; however, its function in the cardiovascular system appears to be even more complex and conflicting. To characterize miR-21 expression in the plasma of individuals with or without metabolic syndrome （MetS）, 58 MetS cases and 96 non-MetS controls were investigated.
基金
supported by Qianjiang Talents Project of Science Technology Department of Zhejiang Province(project number 2013R10078)(http://www.zjkjt.gov.cn/)
Medical and Health Science Research Fund of Zhejiang Province(project number 2013KYB053,2008A034,2007A035,2006A019)(http://www.zjwst.gov.cn)
